Nifty
Sensex
:
:
11196.50
37892.36
101.25 (0.91%)
204.45 (0.54%)

Pharmaceuticals & Drugs - Domestic

Rating :
89/99

BSE: 506820 | NSE: ASTRAZEN

3417.85
04-Aug-2020
  • Open
  • High
  • Low
  • Previous Close
  •  3410.00
  •  3459.85
  •  3390.95
  •  3390.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  76084
  •  2600.74
  •  3670.00
  •  1632.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,538.88
  • 118.25
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,286.35
  • 0.01%
  • 23.53

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 2.95%
  • 16.50%
  • FII
  • DII
  • Others
  • 1.19%
  • 3.25%
  • 1.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.43
  • 8.09
  • 13.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.52
  • 49.03
  • 21.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.19
  • 68.86
  • 40.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 83.17
  • 113.75
  • 111.75

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.52
  • 20.52
  • 20.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 42.19
  • 64.09
  • 56.33

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma gets import, market permission from DCGI for Dapagliflozin film coated tablet
    6th Jul 2020, 08:52 AM

    Dapagliflozin film coated tablet 10mg is additional indication in adults for the treatment of heart failure with reduced ejection fraction

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.